<DOC>
	<DOCNO>NCT00793273</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study observe efficacy Levemir速 treatment patient type 2 diabetes everyday clinical practice Switzerland . Furthermore time period diagnosis type 2 diabetes insulin initiation evaluate .</brief_summary>
	<brief_title>Observational Study Observe Efficacy Levemir速 ( Insulin Detemir ) Patients With Type 2 Diabetes .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Patients type 2 diabetes mellitus Insulinnaive currently treat another basal insulin Inclusion patient discretion treat physician decision prescribe Levemir速 Type 1 diabetes mellitus Patients treat short act premix insulin Women pregnant , breast feeding intention become pregnant Known suspect allergy study product related product Any exclusion criterion accord Swiss Levemir速 SPC ( Summary Product Characteristics )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>